循环miRNA在预测非小细胞肺癌转移中的研究进展
Study Progress of Circulating miRNA for Predicting Metastasis in Non-Small Cell Lung Cancer
DOI: 10.12677/acm.2024.1471982, PDF,   
作者: 丛靖靖, 王安娜, 刘凯静, 李红梅*:青岛大学附属医院肿瘤科,山东 青岛;李政霞:诸城市人民医院肿瘤科,山东 潍坊
关键词: 肺癌非小细胞肺癌转移生物标志物循环miRNALung Cancer Non-Small Cell Lung Cancer Metastasis Biomarkers Circulating miRNA
摘要: 肺癌是全球范围内癌症相关死亡的主要原因,非小细胞肺癌(NSCLC)是最常见的病理类型,远处转移是NSCLC相关死亡的重要原因。因此,有必要寻找新型分子生物标志物,识别具有高度转移风险的NSCLC患者,以进行更密切的随访和制定更个性化的治疗方法,从而改善NSCLC患者的生存。由于循环microRNA (miRNA)的诸多优点,如易获取性、高度稳定性、特异性、敏感性,故其作为预测NSCLC转移的分子生物标志物具有广阔的应用前景。本文对循环miRNA作为预测NSCLC转移生物标志物的作用进行了综述,以期为改善NSCLC的预后提供新的策略。
Abstract: Lung cancer is the leading cause of cancer-related deaths worldwide, and non-small cell lung cancer (NSCLC) is the most common pathological type. The main cause of NSCLC-related deaths is distant metastasis. Therefore, it is necessary to find novel biomarkers to identify NSCLC patients with high metastatic risk for closer follow-up and more personalized treatment, thereby improving the survival of NSCLC patients. Because of the advantages, such as easy accessibility, high stability, specificity, and sensitivity, circulating microRNAs (miRNAs) have broad application prospects as molecular biomarkers for predicting NSCLC metastasis. In this review, the role of circulating miRNAs as biomarkers in predicting NSCLC metastasis is reviewed, in order to provide a new strategy for improving the prognosis of NSCLC.
文章引用:丛靖靖, 王安娜, 李政霞, 刘凯静, 李红梅. 循环miRNA在预测非小细胞肺癌转移中的研究进展[J]. 临床医学进展, 2024, 14(7): 65-73. https://doi.org/10.12677/acm.2024.1471982

参考文献

[1] Chen, P., Liu, Y., Wen, Y. and Zhou, C. (2022) Non‐Small Cell Lung Cancer in China. Cancer Communications, 42, 937-970. [Google Scholar] [CrossRef] [PubMed]
[2] Yang, Z., Wang, H., Zhao, Z., Jin, Y., Zhang, Z., Tan, J., et al. (2022) Gene-microRNA Network Analysis Identified Seven Hub Genes in Association with Progression and Prognosis in Non-Small Cell Lung Cancer. Genes, 13, Article 1480. [Google Scholar] [CrossRef] [PubMed]
[3] National Lung Screening Trial Research Team, Aberle, D.R., Adams, A.M., et al. (2011) Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. New England Journal of Medicine, 365, 395-409. [Google Scholar] [CrossRef] [PubMed]
[4] Moyer, V.A. (2014) Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine, 160, 330-338. [Google Scholar] [CrossRef] [PubMed]
[5] Bach, P.B., Mirkin, J.N., Oliver, T.K., Azzoli, C.G., Berry, D.A., Brawley, O.W., et al. (2012) Benefits and Harms of CT Screening for Lung Cancer. JAMA, 307, 2418-2429. [Google Scholar] [CrossRef] [PubMed]
[6] Owens, C., Hindocha, S., Lee, R., Millard, T. and Sharma, B. (2023) The Lung Cancers: Staging and Response, CT, 18F-FDG PET/CT, MRI, DWI: Review and New Perspectives. The British Journal of Radiology, 96, Article ID: 20220339. [Google Scholar] [CrossRef] [PubMed]
[7] Jet, T., Gines, G., Rondelez, Y. and Taly, V. (2021) Advances in Multiplexed Techniques for the Detection and Quantification of microRNAs. Chemical Society Reviews, 50, 4141-4161. [Google Scholar] [CrossRef] [PubMed]
[8] Cheong, J.K., Tang, Y.C., Zhou, L., Cheng, H. and Too, H. (2022) Advances in Quantifying Circulatory microRNA for Early Disease Detection. Current Opinion in Biotechnology, 74, 256-262. [Google Scholar] [CrossRef] [PubMed]
[9] Baldasici, O., Pileczki, V., Cruceriu, D., Gavrilas, L.I., Tudoran, O., Balacescu, L., et al. (2022) Breast Cancer-Delivered Exosomal Mirna as Liquid Biopsy Biomarkers for Metastasis Prediction: A Focus on Translational Research with Clinical Applicability. International Journal of Molecular Sciences, 23, Article 9371. [Google Scholar] [CrossRef] [PubMed]
[10] Ravegnini, G., Gorini, F., De Crescenzo, E., De Leo, A., De Biase, D., Di Stanislao, M., et al. (2021) Can mirnas Be Useful Biomarkers in Improving Prognostic Stratification in Endometrial Cancer Patients? An Update Review. International Journal of Cancer, 150, 1077-1090. [Google Scholar] [CrossRef] [PubMed]
[11] Khan, P., Ebenezer, N.S., Siddiqui, J.A., Maurya, S.K., Lakshmanan, I., Salgia, R., et al. (2022) MicroRNA-1: Diverse Role of a Small Player in Multiple Cancers. Seminars in Cell & Developmental Biology, 124, 114-126. [Google Scholar] [CrossRef] [PubMed]
[12] Marcuello, M., Vymetalkova, V., Neves, R.P.L., Duran-Sanchon, S., Vedeld, H.M., Tham, E., et al. (2019) Circulating Biomarkers for Early Detection and Clinical Management of Colorectal Cancer. Molecular Aspects of Medicine, 69, 107-122. [Google Scholar] [CrossRef] [PubMed]
[13] Friedman, R.C., Farh, K.K., Burge, C.B. and Bartel, D.P. (2008) Most Mammalian mRNAs Are Conserved Targets of microRNAs. Genome Research, 19, 92-105. [Google Scholar] [CrossRef] [PubMed]
[14] Bartel, D.P. (2009) microRNAs: Target Recognition and Regulatory Functions. Cell, 136, 215-233. [Google Scholar] [CrossRef] [PubMed]
[15] Lee, R.C., Feinbaum, R.L. and Ambros, V. (1993) The C. Elegans Heterochronic Gene Lin-4 Encodes Small RNAs with Antisense Complementarity to Lin-14. Cell, 75, 843-854. [Google Scholar] [CrossRef] [PubMed]
[16] Martinez, M.A., Tural, C. and Franco, S. (2022) Circulating microRNAs as a Tool for Diagnosis of Liver Disease Progression in People Living with HIV-1. Viruses, 14, Article 1118. [Google Scholar] [CrossRef] [PubMed]
[17] El-Hefnawy, T., Raja, S., Kelly, L., Bigbee, W.L., Kirkwood, J.M., Luketich, J.D., et al. (2004) Characterization of Amplifiable, Circulating RNA in Plasma and Its Potential as a Tool for Cancer Diagnostics. Clinical Chemistry, 50, 564-573. [Google Scholar] [CrossRef] [PubMed]
[18] Ho, P.T.B., Clark, I.M. and Le, L.T.T. (2022) microRNA-based Diagnosis and Therapy. International Journal of Molecular Sciences, 23, Article 7167. [Google Scholar] [CrossRef] [PubMed]
[19] Jeon, D.S., Kim, H.C., Kim, S.H., Kim, T., Kim, H.K., Moon, M.H., et al. (2023) Five-Year Overall Survival and Prognostic Factors in Patients with Lung Cancer: Results from the Korean Association of Lung Cancer Registry (KALC-R) 2015. Cancer Research and Treatment, 55, 103-111. [Google Scholar] [CrossRef] [PubMed]
[20] Ahn, Y. and Ko, Y.H. (2020) Diagnostic and Therapeutic Implications of microRNAs in Non-Small Cell Lung Cancer. International Journal of Molecular Sciences, 21, Article 8782. [Google Scholar] [CrossRef] [PubMed]
[21] Wei, C., Zhang, R., Cai, Q., Gao, X., Tong, F., Dong, J., et al. (2019) microRNA-330-3P Promotes Brain Metastasis and Epithelial-Mesenchymal Transition via GRIA3 in Non-Small Cell Lung Cancer. Aging, 11, 6734-6761. [Google Scholar] [CrossRef] [PubMed]
[22] Liu, B. and Sun, X. (2019) miR-25 Promotes Invasion of Human Non-Small Cell Lung Cancer via CDH1. Bioengineered, 10, 271-281. [Google Scholar] [CrossRef] [PubMed]
[23] Wu, T., Hu, H., Zhang, T., Jiang, L., Li, X., Liu, S., et al. (2019) miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway. Oxidative Medicine and Cellular Longevity, 2019, Article ID: 9719723. [Google Scholar] [CrossRef] [PubMed]
[24] Zhang, Y., Yuan, J., Guo, M., Xiang, R., Wang, X., Xie, T., et al. (2022) miR-657 Targets SRCIN1 via the Slug Pathway to Promote NSCLC Tumor Growth and EMT Induction. Disease Markers, 2022, Article ID: 4842454. [Google Scholar] [CrossRef] [PubMed]
[25] Huang, X., Xiao, S., Zhu, X., Yu, Y., Cao, M., Zhang, X., et al. (2020) miR-196B-5P-mediated Downregulation of FAS Promotes NSCLC Progression by Activating IL6-STAT3 Signaling. Cell Death & Disease, 11, Article No. 785. [Google Scholar] [CrossRef] [PubMed]
[26] Zhang, P., Li, L., Wang, B., Ran, X., Yang, S., Luo, Y., et al. (2022) miR-489-3p Promotes Malignant Progression of Non-Small Cell Lung Cancer through the Inactivation of Wnt/β-Catenin Signaling Pathway via Regulating USP48. Respiratory Research, 23, Article No. 93. [Google Scholar] [CrossRef] [PubMed]
[27] Zeng, X., Liu, D., Peng, G., Liu, J. and Yang, H. (2022) Mirorna-31-3p Promotes the Invasion and Metastasis of Non-Small-Cell Lung Cancer Cells by Targeting Forkhead Box 1 (FOXO1). Computational and Mathematical Methods in Medicine, 2022, Article ID: 4597087. [Google Scholar] [CrossRef] [PubMed]
[28] Han, L., Zhang, Y., Zhao, B., Yue, J., Chen, Z., Lei, G., et al. (2022) MicroRNA 101 Attenuated NSCLC Proliferation through IDH2/HIFα Axis Suppression in the Warburg Effect. Oxidative Medicine and Cellular Longevity, 2022, Article ID: 4938811. [Google Scholar] [CrossRef] [PubMed]
[29] Shi, J., Wang, H., Feng, W., Huang, S., An, J., Qiu, Y., et al. (2020) MicroRNA-130a Targeting Hypoxia-Inducible Factor 1 α Suppresses Cell Metastasis and Warburg Effect of NSCLC Cells under Hypoxia. Life Sciences, 255, Article ID: 117826. [Google Scholar] [CrossRef] [PubMed]
[30] Liu, J., Jia, Y., Jia, L., Li, T., Yang, L. and Zhang, G. (2019) MicroRNA 615-3p Inhibits the Tumor Growth and Metastasis of NSCLC via Inhibiting IGF2. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, 27, 269-279. [Google Scholar] [CrossRef] [PubMed]
[31] Jiang, F., Yu, Q., Chu, Y., Zhu, X., Lu, W., Liu, Q., et al. (2018) MicroRNA-98-5p Inhibits Proliferation and Metastasis in Non-Small Cell Lung Cancer by Targeting TGFBR1. International Journal of Oncology, 54, 128-138. [Google Scholar] [CrossRef] [PubMed]
[32] Lu, G. and Zhang, Y. (2019) MicroRNA-340-5p Suppresses Non-Small Cell Lung Cancer Cell Growth and Metastasis by Targeting ZNF503. Cellular & Molecular Biology Letters, 24, Article No. 34. [Google Scholar] [CrossRef] [PubMed]
[33] Gao, J., Feng, X., Wang, F., Wang, J., Wang, H., Li, H., et al. (2019) MicroRNA-448 Inhibits the Progression of Non‐Small-Cell Lung Cancer through Regulating IRS2. Journal of Cellular Biochemistry, 120, 13453-13463. [Google Scholar] [CrossRef] [PubMed]
[34] Huang, R., Zheng, Y., Li, C., Ding, C., Xu, C. and Zhao, J. (2018) MicroRNA-485-5p Suppresses Growth and Metastasis in Non-Small Cell Lung Cancer Cells by Targeting IGF2BP2. Life Sciences, 199, 104-111. [Google Scholar] [CrossRef] [PubMed]
[35] Bai, X., He, C., Fu, B., Kong, X., Bu, J., Zhu, K., et al. (2020) MicroRNA-877 Contributes to Decreased Non-Small Cell Lung Cancer Cell Growth via the PI3K/AKT Pathway by Targeting Tartrate Resistant Acid Phosphatase 5 Activity. Cell Cycle, 19, 3260-3276. [Google Scholar] [CrossRef] [PubMed]
[36] Khandelwal, A., Sharma, U., Barwal, T.S., Seam, R.K., Gupta, M., Rana, M.K., et al. (2021) Circulating miR-320a Acts as a Tumor Suppressor and Prognostic Factor in Non-Small Cell Lung Cancer. Frontiers in Oncology, 11, Article 645475. [Google Scholar] [CrossRef] [PubMed]
[37] Liu, F., Li, T., Hu, P. and Dai, L. (2021) Upregulation of Serum Mir-629 Predicts Poor Prognosis for Non-Small-Cell Lung Cancer. Disease Markers, 2021, Article ID: 8819934. [Google Scholar] [CrossRef] [PubMed]
[38] Soliman, S.E., Abdelaleem, A.H., Alhanafy, A.M., Ibrahem, R.A.L., Elhaded, A.S.A. and Assar, M.F.A. (2021) Circulating miR-21-5p and miR-126-3p: Diagnostic, Prognostic Value, and Multivariate Analysis in Non-Small-Cell Lung Cancer. Molecular Biology Reports, 48, 2543-2552. [Google Scholar] [CrossRef] [PubMed]
[39] Chen, L., Li, Y. and Lu, J. (2020) Identification of Circulating Mir-762 as a Novel Diagnostic and Prognostic Biomarker for Non-Small Cell Lung Cancer. Technology in Cancer Research & Treatment, 19. [Google Scholar] [CrossRef] [PubMed]
[40] Torres, A.G., Fabani, M.M., Vigorito, E. and Gait, M.J. (2011) MicroRNA Fate upon Targeting with Anti-Mirna Oligonucleotides as Revealed by an Improved Northern-Blot-Based Method for miRNA Detection. RNA, 17, 933-943. [Google Scholar] [CrossRef] [PubMed]
[41] Gines, G., Menezes, R., Xiao, W., Rondelez, Y. and Taly, V. (2020) Emerging Isothermal Amplification Technologies for MicroRNA Biosensing: Applications to Liquid Biopsies. Molecular Aspects of Medicine, 72, Article ID: 100832. [Google Scholar] [CrossRef] [PubMed]
[42] Tiberio, P., Callari, M., Angeloni, V., Daidone, M.G. and Appierto, V. (2015) Challenges in Using Circulating miRNAs as Cancer Biomarkers. BioMed Research International, 2015, Article ID: 731479. [Google Scholar] [CrossRef] [PubMed]
[43] Brittain, W.J., Brandsetter, T., Prucker, O. and Rühe, J. (2019) The Surface Science of Microarray Generation—A Critical Inventory. ACS Applied Materials & Interfaces, 11, 39397-39409. [Google Scholar] [CrossRef] [PubMed]
[44] Wong, R.K.Y., MacMahon, M., Woodside, J.V. and Simpson, D.A. (2019) A Comparison of RNA Extraction and Sequencing Protocols for Detection of Small RNAs in Plasma. BMC Genomics, 20, Article No. 446. [Google Scholar] [CrossRef] [PubMed]
[45] Ali, M.M., Li, F., Zhang, Z., Zhang, K., Kang, D., Ankrum, J.A., et al. (2014) Rolling Circle Amplification: A Versatile Tool for Chemical Biology, Materials Science and Medicine. Chemical Society Reviews, 43, 3324-3341. [Google Scholar] [CrossRef] [PubMed]
[46] Xu, L., Duan, J., Chen, J., Ding, S. and Cheng, W. (2021) Recent Advances in Rolling Circle Amplification-Based Biosensing Strategies—A Review. Analytica Chimica Acta, 1148, 238187. [Google Scholar] [CrossRef] [PubMed]
[47] Das, S., Devireddy, R. and Gartia, M.R. (2023) Surface Plasmon Resonance (SPR) Sensor for Cancer Biomarker Detection. Biosensors, 13, Article 396. [Google Scholar] [CrossRef] [PubMed]
[48] Singh, G.P. and Sardana, N. (2022) Smartphone-based Surface Plasmon Resonance Sensors: A Review. Plasmonics, 17, 1869-1888. [Google Scholar] [CrossRef] [PubMed]
[49] Guo, X., Li, J., Arabi, M., Wang, X., Wang, Y. and Chen, L. (2020) Molecular-Imprinting-Based Surface-Enhanced Raman Scattering Sensors. ACS Sensors, 5, 601-619. [Google Scholar] [CrossRef] [PubMed]
[50] Li, M., Qiu, Y., Fan, C., Cui, K., Zhang, Y. and Xiao, Z. (2018) Design of SERS Nanoprobes for Raman Imaging: Materials, Critical Factors and Architectures. Acta Pharmaceutica Sinica B, 8, 381-389. [Google Scholar] [CrossRef] [PubMed]
[51] Wu, J., Zhou, X., Li, P., Lin, X., Wang, J., Hu, Z., et al. (2021) Ultrasensitive and Simultaneous SERS Detection of Multiplex MicroRNA Using Fractal Gold Nanotags for Early Diagnosis and Prognosis of Hepatocellular Carcinoma. Analytical Chemistry, 93, 8799-8809. [Google Scholar] [CrossRef] [PubMed]
[52] Kirschner, M.B., Kao, S.C., Edelman, J.J., Armstrong, N.J., Vallely, M.P., van Zandwijk, N., et al. (2011) Haemolysis during Sample Preparation Alters MicroRNA Content of Plasma. PLOS ONE, 6, e24145. [Google Scholar] [CrossRef] [PubMed]
[53] Cheng, H.H., Yi, H.S., Kim, Y., Kroh, E.M., Chien, J.W., Eaton, K.D., et al. (2013) Plasma Processing Conditions Substantially Influence Circulating MicroRNA Biomarker Levels. PLOS ONE, 8, e64795. [Google Scholar] [CrossRef] [PubMed]
[54] Mestdagh, P., Hartmann, N., Baeriswyl, L., Andreasen, D., Bernard, N., Chen, C., et al. (2014) Evaluation of Quantitative Mirna Expression Platforms in the MicroRNA Quality Control (miRQC) Study. Nature Methods, 11, 809-815. [Google Scholar] [CrossRef] [PubMed]
[55] Fehlmann, T., Lehallier, B., Schaum, N., Hahn, O., Kahraman, M., Li, Y., et al. (2020) Common Diseases Alter the Physiological Age-Related Blood MicroRNA Profile. Nature Communications, 11, Article No. 5958. [Google Scholar] [CrossRef] [PubMed]